Strategic Moves by HLB BioStep: Enhancing Shareholder Value through Share Repurchase
HLB BioStep, a subsidiary of HLB Group, recently announced a significant move to acquire treasury shares worth 3 billion KRW (approximately 2.5 million USD). This decision, disclosed on the 21st, is aimed at bolstering shareholder value and reflects the company’s confidence in its growth potential. The share repurchase is part of a broader strategy to … 더 읽기